乌鸦传媒

Incidence almost identical to that with standard cancer treatment in randomized trials

Systematic review and meta-analysis finds CAR T-cell-specific toxicities only account for 11.5%

Better survival in one registry study, detriment with class I HLA mismatch in another

News, features, and commentary about cancer-related issues

News, features, and commentary about cancer-related issues

News, features, and commentary about cancer-related issues

Indicated for newly diagnosed patients who are eligible for stem cell transplant

A third of patients who had received multiple prior lines of therapy responded, small study shows

News, features, and commentary about cancer-related issues

Joseph Mikhael, MD, leads a discussion on the DREAMM-7 and DREAMM-8 trials

Joseph Mikhael, MD, leads a discussion on the subgroup analysis of CARTITUDE-4

Case reports may not be as reliable, researchers say

Joseph Mikhael, MD, leads a discussion on the findings of the MRD2STOP study

Joseph Mikhael, MD, leads a roundtable discussion on two positive phase III trials from ASCO